Companies: 10,793     total market cap: โ‚น12471.243 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
BioCryst Pharmaceuticals
BCRX
#4410
Rank
โ‚น218.62 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น871.69
Share price
-0.95%
Change (1 day)
49.23%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of December 2025 : โ‚น47.78 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are โ‚น47.78 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31โ‚น46.15 B9.71%
2024-12-31โ‚น42.07 B-2.24%
2023-12-31โ‚น43.03 B-5.44%
2022-12-31โ‚น45.51 B3.96%
2021-12-31โ‚น43.77 B78.83%
2020-12-31โ‚น24.47 B95.84%
2019-12-31โ‚น12.49 B21.74%
2018-12-31โ‚น10.26 B-9.79%
2017-12-31โ‚น11.38 B86.42%
2016-12-31โ‚น6.10 B-24.91%
2015-12-31โ‚น8.13 B-6.26%
2014-12-31โ‚น8.67 B187.35%
2013-12-31โ‚น3.01 B-4.01%
2012-12-31โ‚น3.14 B-27.68%
2011-12-31โ‚น4.34 B-11.33%
2010-12-31โ‚น4.90 B-25.67%
2009-12-31โ‚น6.59 B62.08%
2008-12-31โ‚น4.07 B-27.32%
2007-12-31โ‚น5.60 B84.65%
2006-12-31โ‚น3.03 B-32.08%
2005-12-31โ‚น4.46 B217.62%
2004-12-31โ‚น1.40 B2.62%
2003-12-31โ‚น1.37 B-30.81%
2002-12-31โ‚น1.98 B-30.54%
2001-12-31โ‚น2.85 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
โ‚น5.485 T 11,379.55%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น7.649 T 15,908.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น311.29 B 551.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น274.11 B 473.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น109.33 B 128.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น54.17 B 13.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น0.77 B-98.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น2.61 B-94.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น135.77 B 184.15%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com